Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$138.54 USD

138.54
1,169,708

+6.29 (4.76%)

Updated May 24, 2024 04:00 PM ET

After-Market: $138.53 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Founded in 1994 and headquartered in Denver, CO, DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales

Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.

Stereotaxis (STXS) Inks Deal to Buy Access Point Technologies

Stereotaxis' (STXS) deal to acquire electrophysiology catheter developer, Access Point Technologies, is likely to strengthen its position within the catheter market.

Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication

Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.

Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?

Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.

Reasons to Add The Cooper Companies (COO) to Your Portfolio

The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.

Three Reasons to Retain Integer Holdings (ITGR) Stock for Now

Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.

Catalent's (CTLT) Latest Partnership to Boost Clinical Trials

Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.

Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?

Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks.com featured highlights Hasbro, Brinker International, DaVita, Leidos Holdings and Allstate

Hasbro, Brinker International, DaVita, Leidos Holdings and Allstate have been highlighted in this Screen of The Week article.

Vasundhara Sawalka headshot

5 Stocks Trading Near 52-Week High With More Upside Potential

Investors target stocks that have lately been on a bull run. Stocks like HAS, EAT, DVA, LDOS and ALL are seeing price strength and have a high chance of carrying the momentum forward.

Tirthankar Chakraborty headshot

4 Must-Buy Momentum Stocks Banking on the Driehaus Strategy

DaVita (DVA), Minerals Technologies (MTX), Alphabet (GOOGL) and Garmin (GRMN) have been selected as the momentum picks for the day using the Driehaus strategy.

Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and The Pennant Group

DaVita, Encompass Health, Option Care Health and The Pennant Group have been highlighted in this Industry Outlook article.

Debanjana Dey headshot

4 Stocks to Buy in a Thriving Outpatient Home Health Industry

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.

The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant

DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant are included in this Analyst Blog.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Are Medical Stocks Lagging DaVita (DVA) This Year?

Here is how DaVita HealthCare (DVA) and Alcon (ALC) have performed compared to their sector so far this year.

Nalak Das headshot

Top 5 Outpatient and Home Healthcare Stocks for Solid Returns

We have narrowed our search to outpatient and home healthcare stocks that have strong growth potential for 2024. These are: DVA, ADUS, OPCH, EHC, PNTG.

Is DaVita (DVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

DaVita HealthCare (DVA) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

New Strong Buy Stocks for May 6th

ROOT, SMCI, PPC, DFH and DVA have been added to the Zacks Rank #1 (Strong Buy) List on May 6, 2024.

Best Value Stocks to Buy for May 6th

DFH, DVA and BDC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 6, 2024.

DaVita (DVA) Q1 Earnings & Revenues Top Estimates, Margins Up

DaVita's (DVA) robust segmental revenues drive its first-quarter performance.